Physician profile
Monica J Forth
NPI 1447295506
$2,585.26
in general payments reported to CMS, 2019-2025
38 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $206 · 2021: $559 · 2022: $600 · 2023: $179 · 2024: $597 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $469.84 | 2019-2025 | Breztri, Flumist Quadrivalent, Farxiga |
| Novo Nordisk INC | $329.87 | 2020-2024 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $203.17 | 2019-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $182.08 | 2021-2024 | |
| Pfizer INC. | $148.52 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $147.97 | 2021-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.54 | 2019-2025 | Jardiance |
| Abbott Laboratories | $97.10 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $84.81 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $77.10 | 2022 | |
| Vanda Pharmaceuticals INC. | $76.89 | 2024 | Fanapt, Hetlioz |
| Dexcom, INC. | $57.37 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $56.44 | 2019-2022 | |
| Astellas Pharma US INC | $54.13 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $40.69 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Forth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.